Editorial standards
Securities-backed lending is a financial subject where accuracy matters. This page sets out, plainly, how the content on this site is written, where its regulatory statements come from, how its figures are treated, and how to tell us if something is wrong.
What this content is — and is not.
The pages on this site are educational. They explain how institutional securities-backed lending works, how it differs from adjacent instruments, and how the treatment of a pledge varies from one market to the next. They are written to be understood by substantial shareholders and their advisers, not to sell a product.
Nothing on this site is personalised legal, tax, investment, or accounting advice, and nothing on it is an offer or a solicitation. General explanations cannot account for an individual holder’s position, jurisdiction, or objectives. Any figure, structure, or regulatory point described here should be confirmed with a qualified professional adviser and against the relevant primary sources before it is relied upon. The full legal position is set out in the disclosures.
Regulatory points trace to named regulators.
Where a page states a regulatory fact — a disclosure threshold, a beneficial-ownership regime, an insider-dealing or takeover rule — that statement is drawn from the framework of the official regulator or exchange for the market in question, and the framework is named on the page so it can be checked at source.
These are the principal official regulators and rulebooks the market pages cite. Each links to the regulator’s own website, which is the authoritative source; where the two differ, the primary source governs.
- ·United States — U.S. Securities and Exchange Commission (SEC); the Schedule 13D/13G beneficial-ownership framework under Section 13(d) of the Securities Exchange Act of 1934.
- ·United Kingdom — Financial Conduct Authority (FCA); the Disclosure Guidance and Transparency Rules (DTR 5). Takeovers: the Takeover Panel.
- ·
- ·
- ·Germany — Federal Financial Supervisory Authority (BaFin); the voting-rights notification regime under the Securities Trading Act (WpHG).
- ·Japan — Financial Services Agency (FSA); the large-shareholding reporting regime under the Financial Instruments and Exchange Act.
- ·Australia — Australian Securities and Investments Commission (ASIC); the substantial-holding provisions of the Corporations Act 2001.
- ·Other covered markets — each market page names the official regulator, self-regulatory body, and rulebook for that jurisdiction (for example Canada’s CSA, Singapore’s MAS, India’s SEBI, Saudi Arabia’s CMA). The named regulator’s own publications are the authoritative source.
Regulatory regimes change. A citation on this site reflects the framework as the page understood it at the time of writing, and each market page is a summary rather than a substitute for the primary rules. Regulations should be verified against the relevant regulator’s current publications, as noted in the disclosures.
Figures are indicative, and labelled as such.
This site does not publish a rate card, and it does not quote loan-to-value ratios, coupons, or transaction sizes as fixed offers. Where ranges appear — for example, that institutional tenors are typically twelve to thirty-six months — they are indicative of common institutional practice, not a commitment applicable to any particular position.
- ·No published pricing. Loan-to-value and pricing are calibrated per position after review. Indicative terms for a specific position are issued only after that review, not from this website.
- ·Ranges are illustrative. Tenor bands, recourse profiles, and process timings describe how transactions are commonly structured; they are not guarantees, and an individual transaction may fall outside them.
- ·Reviewed for internal consistency. Recurring figures — tenor bands, market and exchange counts, process timings — are kept consistent across the site, so the same fact reads the same way wherever it appears.
- ·No invented statistics. The site does not publish deal counts, assets-under-management figures, client testimonials, awards, or press claims, because those figures are not maintained for publication here.
Written by the firm’s principals.
The insight articles and reference material on this site are written under the names of the firm’s senior principals, whose backgrounds are set out on the about page. Each insight article carries a named author and a “written by” note; the market and use-case pages are prepared by the same team.
- ·Etienne Marchand, Managing Principal — the instrument, structuring, and use-case material.
- ·Camille Rousseau, Principal, Structuring & Risk — loan-to-value calibration, recourse profiles, custody, and disclosure mechanics.
- ·Adrien Fontaine, Principal, Markets & Coverage — per-market eligibility, regulatory frameworks, and cross-currency considerations.
This site does not maintain an external editorial board, and it does not claim third-party review, certification, or accreditation that it does not hold. The authorship above is the firm’s own team; where a topic touches legal, tax, or accounting matters, readers are directed to their own professional advisers rather than to a claim of in-house expert review.
An introducer and arranger.
The firm acts as an introducer and arranger of securities-backed financing transactions. It is not a deposit-taker, not a discretionary investment manager, and does not hold itself out as a regulated investment adviser except to the extent expressly stated in writing at the point of engagement. Activities requiring a regulatory licence are conducted through, or in collaboration with, entities holding the appropriate licence or registration in the relevant jurisdiction.
This posture shapes the content: the site explains the instrument and the markets, and describes the structuring discipline, but it stops short of advice tailored to a reader’s circumstances. The firm’s legal entity, registered office, and regulatory profile are stated on the about page and in the disclosures.
If something here is wrong, tell us.
If you find an error on this site — a mis-stated regulatory point, an out-of-date citation, a figure that reads inconsistently, or a broken reference — we would like to correct it. Accuracy is the point of this page, and a correction that improves it is welcome.
Write to [email protected] with the page, the statement in question, and, where possible, the primary source that supports the correction. Substantive corrections are reflected on the page, and the page’s modification date is updated when material content changes.
Questions about a specific position?
General explanations only go so far. For a position-specific conversation, submit a confidential enquiry.